DELRAY BEACH, Fla., Feb. 15, 2022 /PRNewswire/ — UpHealth, Inc. (NYSE: UPH) today announced that its HelloLyf™ CX digital dispensaries have surpassed 2 million consultations in India. The annual run rate of 2 million consults is rising rapidly and is expected to increase threefold within 12 months.
UpHealth currently operates over 600 digital dispensaries globally in India, providing quality digital healthcare with measurable results, outperforming the most elaborate healthcare systems.
The digital dispensaries provide a complete primary and emergency healthcare solution from start to finish through consultation, confirmatory tests and dispensed medications. Consults in the digital dispensaries are efficient, requiring only 30 minutes on average, and include:
“With our vast reservoir of doctors, extensive reach and commitment to healthcare access for all, these digital dispensaries are steering health and technology in directions that benefit local, national and global communities. We are making healthcare accessible in rural locations in India while also dramatically lowering the cost of healthcare for patients,” said Dr. Sabahat Azim, International CEO of UpHealth.
“This milestone is another proven example of UpHealth’s dedication to taking healthcare to the next level and creating a world in which everyone, everywhere, can enjoy their best health through quality care.”
The top-performing HelloLyf CX digital dispensaries are currently averaging 48 daily consults with 168,000 consults occurring in January alone. This exponential growth in the number of consults has doubled its pace each year. All 600 clinics are expected to reach around 7 million consults per year. In addition, UpHealth is adding even more dispensaries across more regions.
The tech-led, remote process allows patients to receive faster care with shorter wait times, which average less than 10 minutes.
Nearly 70 percent of India’s population is located in rural areas that lack organized healthcare.
“India’s rural population is discerning and prefers innovative solutions to healthcare access,” said Richa Azim, president of Glocal Healthcare, the international arm of UpHealth. “They want to be seen by established physicians from major cities without having to take on travel expenses.”
HelloLyf enables patients to request a specific physician if they have virtually “seen” that physician at the dispensary previously or if they want to be seen by a specialist.
About UpHealth
UpHealth is a global digital health company that delivers digital-first technology, infrastructure, and services to dramatically improve how healthcare is delivered and managed. UpHealth’s solutions holistically enable clients to deliver on their affordability, access, quality, outcomes, and patient experience goals. UpHealth’s technology platform helps its clients improve access, coordinate care teams, and achieve better patient outcomes at lower cost, with care management solutions, analytics, and telehealth tools that serve patients wherever they are, in their native language. Additionally, UpHealth’s technology-enabled virtual care infrastructure and services improves access to quality primary and acute care, behavioral health, and pharmacy services. UpHealth’s clients include health plans, global governments, healthcare providers and community-based organizations.
For more information, please visit https://uphealthinc.com and follow us at @UpHealthInc on Twitter and UpHealth Inc on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/uphealth-reaches-2-million-patient-consults-milestone-across-digital-dispensaries-in-india-301482601.html
SOURCE UpHealth, Inc.
Research highlights how nutrition tracking drives success for weight loss and health goals NEW YORK,…
Coeptis Aims to Bring AI Innovation in Biotechnology and Technology WEXFORD, Pa., Dec. 26, 2024…
Slovenia, Croatia, Turkey, and Greece Drive EHR Adoption in the Balkans, Setting New Standards in…
Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…